Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FBIO |
---|---|---|
09:32 ET | 18554 | 1.945 |
09:34 ET | 1350 | 1.94 |
09:36 ET | 2820 | 1.945 |
09:38 ET | 2726 | 1.92 |
09:41 ET | 13523 | 1.89 |
09:43 ET | 4050 | 1.9 |
09:48 ET | 1004 | 1.8913 |
09:50 ET | 1901 | 1.89 |
09:52 ET | 11748 | 1.87 |
09:54 ET | 700 | 1.8701 |
09:56 ET | 2352 | 1.87 |
09:57 ET | 300 | 1.865 |
09:59 ET | 15814 | 1.87 |
10:01 ET | 500 | 1.89 |
10:03 ET | 1406 | 1.89 |
10:06 ET | 200 | 1.89 |
10:08 ET | 1160 | 1.88 |
10:10 ET | 2200 | 1.88 |
10:12 ET | 100 | 1.885 |
10:14 ET | 12927 | 1.885 |
10:17 ET | 1600 | 1.8897 |
10:19 ET | 550 | 1.9 |
10:21 ET | 6296 | 1.9007 |
10:24 ET | 2320 | 1.91 |
10:28 ET | 2307 | 1.9 |
10:30 ET | 2100 | 1.9006 |
10:32 ET | 11425 | 1.89 |
10:33 ET | 7554 | 1.9 |
10:35 ET | 536 | 1.9095 |
10:37 ET | 187 | 1.9044 |
10:39 ET | 800 | 1.8997 |
10:42 ET | 7500 | 1.89 |
10:44 ET | 100 | 1.899 |
10:46 ET | 500 | 1.895 |
10:50 ET | 5232 | 1.885 |
10:53 ET | 265 | 1.88 |
10:55 ET | 3400 | 1.89 |
10:57 ET | 100 | 1.89 |
11:00 ET | 3797 | 1.9017 |
11:02 ET | 1000 | 1.8987 |
11:04 ET | 1792 | 1.88 |
11:06 ET | 700 | 1.89 |
11:09 ET | 700 | 1.89 |
11:15 ET | 700 | 1.8884 |
11:24 ET | 336 | 1.8896 |
11:26 ET | 273 | 1.8809 |
11:31 ET | 1500 | 1.885 |
11:33 ET | 1000 | 1.8807 |
11:42 ET | 1000 | 1.8808 |
11:44 ET | 100 | 1.885 |
11:45 ET | 2652 | 1.885 |
11:47 ET | 1500 | 1.8899 |
11:49 ET | 520 | 1.885 |
11:54 ET | 400 | 1.8899 |
11:56 ET | 5056 | 1.871 |
11:58 ET | 2016 | 1.86 |
12:02 ET | 241 | 1.878 |
12:03 ET | 5970 | 1.89 |
12:05 ET | 1400 | 1.8801 |
12:12 ET | 3006 | 1.89 |
12:18 ET | 100 | 1.88 |
12:20 ET | 1058 | 1.88 |
12:21 ET | 100 | 1.89 |
12:25 ET | 3000 | 1.8899 |
12:34 ET | 100 | 1.885 |
12:38 ET | 500 | 1.88 |
12:39 ET | 100 | 1.8793 |
12:43 ET | 740 | 1.8707 |
12:45 ET | 500 | 1.88 |
12:48 ET | 3905 | 1.8799 |
12:50 ET | 587 | 1.875 |
12:52 ET | 100 | 1.875 |
12:54 ET | 6000 | 1.8753 |
12:56 ET | 100 | 1.88 |
12:57 ET | 500 | 1.8799 |
12:59 ET | 201 | 1.875 |
01:03 ET | 1700 | 1.875 |
01:08 ET | 4100 | 1.8799 |
01:10 ET | 258 | 1.885 |
01:12 ET | 1450 | 1.88 |
01:14 ET | 300 | 1.8701 |
01:19 ET | 900 | 1.87 |
01:21 ET | 100 | 1.88 |
01:30 ET | 113 | 1.88 |
01:33 ET | 3900 | 1.87 |
01:35 ET | 3503 | 1.87 |
01:53 ET | 3100 | 1.87 |
02:02 ET | 222 | 1.865 |
02:04 ET | 2809 | 1.87 |
02:06 ET | 1200 | 1.8699 |
02:08 ET | 3875 | 1.87 |
02:09 ET | 600 | 1.875 |
02:20 ET | 2500 | 1.8797 |
02:24 ET | 1087 | 1.89 |
02:27 ET | 490 | 1.8893 |
02:33 ET | 125 | 1.8801 |
02:36 ET | 100 | 1.88 |
02:38 ET | 463 | 1.876 |
02:40 ET | 1990 | 1.88 |
02:42 ET | 687 | 1.8701 |
02:44 ET | 300 | 1.88 |
02:45 ET | 400 | 1.87 |
02:47 ET | 300 | 1.875 |
02:51 ET | 1200 | 1.8798 |
02:54 ET | 868 | 1.88 |
03:00 ET | 1400 | 1.885 |
03:03 ET | 3730 | 1.885 |
03:05 ET | 1100 | 1.8864 |
03:07 ET | 1880 | 1.89 |
03:12 ET | 100 | 1.895 |
03:14 ET | 1300 | 1.895 |
03:18 ET | 914 | 1.8941 |
03:20 ET | 650 | 1.895 |
03:21 ET | 7002 | 1.895 |
03:23 ET | 200 | 1.895 |
03:27 ET | 100 | 1.9 |
03:30 ET | 10120 | 1.8995 |
03:32 ET | 1104 | 1.895 |
03:34 ET | 10957 | 1.895 |
03:39 ET | 7646 | 1.895 |
03:41 ET | 1345 | 1.9 |
03:43 ET | 1000 | 1.895 |
03:48 ET | 800 | 1.8988 |
03:50 ET | 2054 | 1.9 |
03:52 ET | 17633 | 1.9 |
03:54 ET | 17672 | 1.9 |
03:56 ET | 4180 | 1.925 |
03:57 ET | 1200 | 1.915 |
03:59 ET | 23194 | 1.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Fortress Biotech Inc | 53.5M | -0.5x | --- |
Cannabis Bioscience International Holdings Inc | 7.4M | 0.0x | --- |
Aytu Biopharma Inc | 12.2M | -0.7x | --- |
Wuhan General Group (China) Inc | 5.5K | 0.0x | --- |
CytomX Therapeutics Inc | 77.5M | 7.3x | --- |
MDxHealth SA | 96.5M | -1.3x | --- |
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases and gene therapy. Its dermatology products include Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm and Luxamend. Its late stage product candidates include Cosibelimab (anti-PD-L1 antibody), DFD-29 (modified release oral minocycline for the treatment of rosacea), CUTX-101 (copper histidinate injection for Menkes disease), IV Tramadol, Olafertinib (also known as CK-101, EGFR inhibitor for EGFR mutation-positive NSCLC), CAEL-101 (monoclonal antibody for AL amyloidosis) and Triplex (cytomegalovirus (CMV) vaccine).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $53.5M |
---|---|
Revenue (TTM) | $82.6M |
Shares Outstanding | 27.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.79 |
EPS | $-3.71 |
Book Value | $1.49 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.